{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:32:58Z","timestamp":1786692778586,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kaleida Troup Funding","award":["030GRT00000091"],"award-info":[{"award-number":["030GRT00000091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral ulcerative mucositis (OUM) is a frequent and severe complication of hematopoietic cell transplantation (HCT). Whether prolonged hospital discharge timing, used as a proxy for extended length of stay (LOS), identifies greater systemic morbidity among patients who develop OUM remains unclear. This retrospective cohort study aimed to evaluate, among HCT recipients with documented OUM, whether prolonged discharge timing is independently associated with increased systemic complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study utilized the National Inpatient Sample to identify adult patients with leukemia or multiple myeloma undergoing autologous or allogeneic HCT complicated by OUM. Patients were stratified by discharge timing: autologous HCT, 10\u201319 (control) vs. 20\u201329 days; allogeneic HCT, 15\u201324 (control) vs. 25\u201334 days. Further, no control group of patients undergoing HCT without OUM was examined. Baseline characteristics and systemic outcomes\u2014including healthcare-associated complications incorporating septicemias, isolated septicemia, coagulopathies, hypertension, and congestive heart failure\u2014were compared. Survey-weighted multivariable logistic regression estimated adjusted odds ratios (aOR) for outcomes in prolonged versus shorter discharge strata, adjusting for demographics and comorbidity burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among autologous HCT recipients with OUM (weighted\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091290), 21.7% experienced prolonged discharge. This stratum had significantly higher adjusted rates of healthcare-associated complications, including septicemias (aOR 3.09, 95% CI: 1.45\u20136.59), isolated septicemia (aOR 4.68, 95% CI: 1.83\u201311.96), and congestive heart failure (aOR 1.68, 95% CI: 2.44\u201311.58). Among allogeneic HCT recipients (weighted\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009885), 54.2% had prolonged discharge, associated with increased healthcare-associated complications including septicemias (aOR 3.3, 95% CI: 1.19\u20139.12), coagulopathies (aOR 3.47 with 95% CI: 1.33\u20139.03), and hypertension (aOR 2.00 with 95%CI: 1.05\u20133.82). No adverse outcomes occurred in discharges within 0\u201310 days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prolonged discharge timing in HCT patients with OUM is independently associated with substantial systemic morbidity, including septicemia-related complications. Discharge-based stratification highlights high-risk periods amenable to targeted supportive interventions to mitigate complications and facilitate earlier safe discharge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00784-026-07037-w","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:16:08Z","timestamp":1784603768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stratified discharge timing within mucositis cases and its association with systemic complications in hematopoietic stem cell transplant recipients: insights from a national inpatient study"],"prefix":"10.1007","volume":"30","author":[{"given":"Sana","family":"Raheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Meleveedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J. M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucky L. A.","family":"van Gennip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauryn","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-6627","authenticated-orcid":false,"given":"Poolakkad S.","family":"Satheeshkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"8","key":"7037_CR1","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201\u20132205. https:\/\/doi.org\/10.1200\/JCO.2001.19.8.2201","journal-title":"J Clin Oncol"},{"issue":"3","key":"7037_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza B, Sandmaier BM (2014) Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 124(3):344\u2013353. https:\/\/doi.org\/10.1182\/blood-2014-02-514778","journal-title":"Blood"},{"issue":"11","key":"7037_CR3","doi-asserted-by":"publisher","first-page":"CD011990","DOI":"10.1002\/14651858.CD011990.pub2","volume":"11","author":"P Riley","year":"2017","unstructured":"Riley P, Glenny AM, Worthington HV, Littlewood A, Fernandez Mauleffinch LM, Clarkson JE, McCabe MG (2017) Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst Rev 11(11):CD011990. https:\/\/doi.org\/10.1002\/14651858.CD011990.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"7037_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.oraloncology.2019.05.013","volume":"95","author":"A Blakaj","year":"2019","unstructured":"Blakaj A, Bonomi M, Gamez ME, Blakaj DM (2019) Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncol 95:29\u201334. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.05.013","journal-title":"Oral Oncol"},{"issue":"5","key":"7037_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12032-017-0950-1","volume":"34","author":"P Franco","year":"2017","unstructured":"Franco P, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M, Ostellino O, Pecorari G, Garzino Demo P, Fasolis M, Airoldi M, Ricardi U (2017) Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Med Oncol 34(5):81. https:\/\/doi.org\/10.1007\/s12032-017-0950-1","journal-title":"Med Oncol"},{"issue":"4","key":"7037_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbmt.2015.09.014","volume":"22","author":"HM Chaudhry","year":"2016","unstructured":"Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, Kremers WK, Phillips GL, Hashmi SK (2016) The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic Review. Biol Blood Marrow Transpl 22(4):605\u2013616","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9 Suppl 4","key":"7037_CR7","first-page":"13","volume":"5","author":"BA Murphy","year":"2007","unstructured":"Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and\/or radiation therapy. J Support Oncol 5(9 Suppl 4):13\u201321","journal-title":"J Support Oncol"},{"issue":"4","key":"7037_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/CCO.0b013e32833a9fab","volume":"22","author":"DE Peterson","year":"2010","unstructured":"Peterson DE, Lalla RV (2010) Oral mucositis: the new paradigms. Curr Opin Oncol 22(4):318\u2013322. https:\/\/doi.org\/10.1097\/CCO.0b013e32833a9fab","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"7037_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ejh.13299","volume":"103","author":"R Shouval","year":"2019","unstructured":"Shouval R, Kouniavski E, Fein J, Danylesko I, Shem-Tov N, Geva M, Yerushalmi R, Shimoni A, Nagler A (2019) Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation. Eur J Haematol 103(4):402\u2013409. https:\/\/doi.org\/10.1111\/ejh.13299","journal-title":"Eur J Haematol"},{"issue":"11","key":"7037_CR10","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.1007\/s00520-022-07328-4","volume":"30","author":"M Nakagaki","year":"2022","unstructured":"Nakagaki M, Kennedy GA, Gavin NC, Clavarino A, Whitfield K (2022) The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation. Support Care Cancer 30(11):9141\u20139149. https:\/\/doi.org\/10.1007\/s00520-022-07328-4","journal-title":"Support Care Cancer"},{"issue":"11","key":"7037_CR11","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s00520-015-2688-7","volume":"23","author":"DT Nguyen","year":"2015","unstructured":"Nguyen DT, Shayani S, Palmer J, Dagis A, Forman SJ, Epstein J, Spielberger R (2015) Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation. Support Care Cancer 23(11):3141\u20133147. https:\/\/doi.org\/10.1007\/s00520-015-2688-7","journal-title":"Support Care Cancer"},{"issue":"16","key":"7037_CR12","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/cancers17162657","volume":"17","author":"S Eichhorn","year":"2025","unstructured":"Eichhorn S, Rudin L, Ramasamy C, Varsani R, Padhi P, Nassour N, Meleveedu K, Epstein JB, Semegran B, Pili R, Satheeshkumar PS (2025) Elevated Likelihood of Infectious Complications Related to Oral Mucositis After Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Outcomes and Risk Factors. Cancers (Basel) 17(16):2657. https:\/\/doi.org\/10.3390\/cancers17162657","journal-title":"Cancers (Basel)"},{"issue":"3","key":"7037_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253\u2013262. https:\/\/doi.org\/10.1016\/s0167-8140(02)00404-8","journal-title":"Radiother Oncol"},{"issue":"5","key":"7037_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00520-006-0176-9","volume":"15","author":"M Vera-Llonch","year":"2007","unstructured":"Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S (2007) Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 15(5):491\u2013496. https:\/\/doi.org\/10.1007\/s00520-006-0176-9","journal-title":"Support Care Cancer"},{"issue":"4","key":"7037_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","volume":"68","author":"LS Elting","year":"2007","unstructured":"Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68(4):1110\u20131120. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.01.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7037_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jhin.2021.02.026","volume":"114","author":"S Stewart","year":"2021","unstructured":"Stewart S, Robertson C, Pan J, Kennedy S, Haahr L, Manoukian S, Mason H, Kavanagh K, Graves N, Dancer SJ, Cook B, Reilly J (2021) Impact of healthcare-associated infection on length of stay. J Hosp Infect 114:23\u201331. https:\/\/doi.org\/10.1016\/j.jhin.2021.02.026","journal-title":"J Hosp Infect"},{"issue":"12","key":"7037_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1086\/668422","volume":"33","author":"CY Jeon","year":"2012","unstructured":"Jeon CY, Neidell M, Jia H, Sinisi M, Larson E (2012) On the role of length of stay in healthcare-associated bloodstream infection. Infect Control Hosp Epidemiol 33(12):1213\u20131218. https:\/\/doi.org\/10.1086\/668422","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"7037_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/10428194.2014.926346","volume":"56","author":"Z Gul","year":"2015","unstructured":"Gul Z, Bashir Q, Cremer M, Yusuf SW, Gunaydin H, Arora S, Slone S, Nieto Y, Sherwani N, Parmar S, Shah N, Dinh YT, Hosing CM, Popat UR, Kebriaei P, Shpall EJ, Giralt SA, Champlin RE, Qazilbash MH (2015) Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma. Leuk Lymphoma 56(2):533\u2013535. https:\/\/doi.org\/10.3109\/10428194.2014.926346","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"7037_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","volume":"15","author":"NS Majhail","year":"2009","unstructured":"Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ (2009) Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl 15(9):1100\u20131107. https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.010","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"7037_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47(6):626\u2013633. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5","journal-title":"Med Care"},{"issue":"7","key":"7037_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","volume":"55","author":"BJ Moore","year":"2017","unstructured":"Moore BJ, White S, Washington R, Coenen N, Elixhauser A (2017) Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index. Med Care 55(7):698\u2013705. https:\/\/doi.org\/10.1097\/MLR.0000000000000735","journal-title":"Med Care"},{"issue":"1","key":"7037_CR22","doi-asserted-by":"publisher","first-page":"e1918668","DOI":"10.1001\/jamanetworkopen.2019.18668","volume":"3","author":"CE Dandoy","year":"2020","unstructured":"Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML, Incidence (2020) Risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. JAMA Netw Open 3(1):e1918668. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18668","journal-title":"JAMA Netw Open"},{"issue":"8","key":"7037_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/671281","volume":"34","author":"I See","year":"2013","unstructured":"See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND (2013) Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol 34(8):769\u2013776","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7037_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/B978-0-323-90242-7.00010-9","volume":"202","author":"M Mikulska","year":"2024","unstructured":"Mikulska M, Gualandi F, Anserini P (2024) Early and late complications of hematopoietic stem cell transplantation. Handb Clin Neurol 202:135\u2013151. https:\/\/doi.org\/10.1016\/B978-0-323-90242-7.00010-9","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"7037_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbmt.2004.12.327","volume":"11","author":"M Mielcarek","year":"2005","unstructured":"Mielcarek M, Gooley T, Martin PJ, Chauncey TR, Young BA, Storb R, Torok-Storb B (2005) Effects of race on survival after stem cell transplantation. Biol Blood Marrow Transpl 11(3):231\u2013239. https:\/\/doi.org\/10.1016\/j.bbmt.2004.12.327","journal-title":"Biol Blood Marrow Transpl"},{"issue":"29","key":"7037_CR26","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","volume":"32","author":"ML Sorror","year":"2014","unstructured":"Sorror ML, Storb RF, Sandmaier BM, Maziarz RT, Pulsipher MA, Maris MB, Bhatia S, Ostronoff F, Deeg HJ, Syrjala KL, Estey E, Maloney DG, Appelbaum FR, Martin PJ, Storer BE (2014) Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. J Clin Oncol 32(29):3249\u20133256","journal-title":"J Clin Oncol"},{"issue":"3","key":"7037_CR27","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00520-021-06625-8","volume":"30","author":"E de Kauark-Fontes Jr","year":"2022","unstructured":"Kauark-Fontes E, Migliorati CA, Epstein JB, Treister NS, Alves CGB, Faria KM, Palmier NR, Rodrigues-Oliveira L, de Pauli Paglioni M, Gueiros LAM, da, Concei\u00e7\u00e3o Vasconcelos KGM, de Castro G Jr, Leme AFP, Lopes MA, Prado-Ribeiro AC, Brand\u00e3o TB, Santos-Silva AR (2022) Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial. Support Care Cancer 30(3):2225\u20132236. https:\/\/doi.org\/10.1007\/s00520-021-06625-8","journal-title":"Support Care Cancer"},{"key":"7037_CR28","doi-asserted-by":"publisher","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC\/ISOO) (2020). MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. ;126(19):4423\u20134431. https:\/\/doi.org\/10.1002\/cncr.33100. Epub 2020 Jul 28. Erratum in: Cancer. 2021;127(19):3700. doi: 10.1002\/cncr.33549. PMID: 32786044; PMCID: PMC7540329","DOI":"10.1002\/cncr.33100"},{"issue":"10","key":"7037_CR29","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1007\/s00520-019-04848-4","volume":"27","author":"CHL Hong","year":"2019","unstructured":"Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society for Oral Oncology (MASCC\/ISOO) (2019) Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27(10):3949\u20133967. https:\/\/doi.org\/10.1007\/s00520-019-04848-4","journal-title":"Support Care Cancer"},{"issue":"11","key":"7037_CR30","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00520-013-1942-0","volume":"21","author":"DB McGuire","year":"2013","unstructured":"McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO) (2013) Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 21(11):3165\u20133177. https:\/\/doi.org\/10.1007\/s00520-013-1942-0","journal-title":"Support Care Cancer"},{"issue":"11","key":"7037_CR31","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00520-009-0771-7","volume":"18","author":"KK Cheng","year":"2010","unstructured":"Cheng KK, Leung SF, Liang RH, Tai JW, Yeung RM, Thompson DR (2010) Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer 18(11):1477\u20131485. https:\/\/doi.org\/10.1007\/s00520-009-0771-7","journal-title":"Support Care Cancer"},{"issue":"1","key":"7037_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00520-024-09071-4","volume":"33","author":"MP Mohan","year":"2024","unstructured":"Mohan MP, Pili R, Epstein JB, Rudin L, Eichhorn S, Satheeshkumar PS (2024) Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients. Support Care Cancer 33(1):22. https:\/\/doi.org\/10.1007\/s00520-024-09071-4","journal-title":"Support Care Cancer"},{"issue":"6","key":"7037_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jaccao.2023.07.007","volume":"5","author":"A Vasbinder","year":"2023","unstructured":"Vasbinder A, Hoeger CW, Catalan T, Anderson E, Chu C, Kotzin M, Xie J, Kaakati R, Berlin HP, Shadid H, Perry D, Pan M, Takiar R, Padalia K, Mills J, Meloche C, Bardwell A, Rochlen M, Blakely P, Leja M, Banerjee M, Riwes M, Magenau J, Anand S, Ghosh M, Pawarode A, Yanik G, Nathan S, Maciejewski J, Okwuosa T, Hayek SS (2023) Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors. JACC CardioOncol 5(6):821\u2013832. https:\/\/doi.org\/10.1016\/j.jaccao.2023.07.007","journal-title":"JACC CardioOncol"},{"issue":"12","key":"7037_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","volume":"25","author":"NM Blijlevens","year":"2000","unstructured":"Blijlevens NM, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transpl 25(12):1269\u20131278. https:\/\/doi.org\/10.1038\/sj.bmt.1702447","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"7037_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/CCM.0000000000000714","volume":"43","author":"G Kumar","year":"2015","unstructured":"Kumar G, Ahmad S, Taneja A, Patel J, Guddati AK, Nanchal R, Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators (2015) Severe sepsis in hematopoietic stem cell transplant recipients*. Crit Care Med 43(2):411\u2013421. https:\/\/doi.org\/10.1097\/CCM.0000000000000714","journal-title":"Crit Care Med"},{"issue":"4","key":"7037_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.13113","volume":"167","author":"WJ van der Velden","year":"2014","unstructured":"van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM (2014) Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 167(4):441\u2013452. https:\/\/doi.org\/10.1111\/bjh.13113","journal-title":"Br J Haematol"},{"issue":"7","key":"7037_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.29271\/jcpsp.2023.07.804","volume":"33","author":"M Ali","year":"2023","unstructured":"Ali M, Kerio AA, Khattak TA, Hussain M, Khan MA, Abbas Y (2023) Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation. J Coll Physicians Surg Pak 33(7):804\u2013808. https:\/\/doi.org\/10.29271\/jcpsp.2023.07.804","journal-title":"J Coll Physicians Surg Pak"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-07037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-026-07037-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-07037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:15:45Z","timestamp":1786691745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-026-07037-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7037"],"URL":"https:\/\/doi.org\/10.1007\/s00784-026-07037-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8780989\/v1","asserted-by":"object"}]},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Include appropriate approvals or waivers.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"353"}}